Corindus, a Siemens Healthineers Company, announced it has been rebranded to Siemens Healthineers Endovascular Robotics, a dedicated business within the Advanced Therapies area of Siemens Healthineers. The aim of the Endovascular Robotics business is to advance interventions with robotics and change the way that care is delivered through innovations that
Cook Medical announced the appointment of John A. Kaufman, MD, MS, as Chief Medical Officer (CMO), effective July 2023. Currently, Dr. Kaufman is the inaugural Chair of the Dotter Department of Interventional Radiology, Director of the Dotter Interventional Institute, and Frederick S. Keller Professor of Interventional Radiology at the Oregon
Merit Medical Systems, Inc. announced the enrollment of the first patient in the company’s prospective, observational study of EmboCube embolization gelatin to control bleeding or hemorrhage. The EmboCube Embolization Gelatin study is designed to enroll 100 patients across multiple centers in Australia and France. The company advised that EmboCube is
The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced observational data from 8 years of clinical practice showing that the company’s oral Factor Xa inhibitor Xarelto (rivaroxaban) is associated with comparable effectiveness and safety to the Factor Xa inhibitor apixaban for the treatment of cancer-associated thromboembolism (CAT) in a
Stryker announced FDA 510(k) clearance of the Target Tetra detachable coil, the latest addition to the company’s Target platform. The Target Tetra device, which is specifically designed to treat small aneurysms, combines a new tetrahedral shape and softness level. According to the company, the delicate nature of small aneurysms makes
Alucent Biomedical Inc. announced that it has enrolled the first patient in ACTIVATE II, an Australia-based first-in-human clinical trial to evaluate the safety and efficacy of AlucentNVS, the company’s natural vascular scaffolding device. According to the company, the ACTIVATE II trial will enroll up to 50 patients at up to
Koya Medical announced the United States commercial availability of its Dayspring active compression system for the treatment of lymphedema and venous diseases in the lower extremities. The company also announced that the Centers for Medicare & Medicaid Services (CMS) issued three new billing codes in accordance with the Healthcare Common
AngioDynamics, Inc. announced the launch of a new clinical study assessing the use of the company’s Auryon atherectomy system in the treatment of calcified lesions in below-the-knee (BTK) arteries. The company announced the commercial launch of the Auryon system in Sep. 2020. The investigator-initiated Auryon BTK study will be conducted
Center For Vein Restoration VISION 2022: March 11th-13th / Washington DC In-Person & Virtual Premier Clinical Convention. 10 + CME Credits. World-Renowned Speakers. 400+ In-Person Attendees and 1400 Virtual Attendees Anticipated. Please visit the VISION 2022 website [hyperlink the text; website is: https://web.cvent.com/event/c94e2be4-dc4c-42ee-92c2-d916e98e5ea8/summary or more information, including the conference agenda.
The 2022 Venous Symposium will be held from April 21–23, 2022 at the Sheraton New York Times Square Hotel. The Venous Symposium is the premier international conference on issues and treatment related to vein pathology. The symposium delivers practical education and updates on the current knowledge and management of venous
OEIS, The Outpatient Endovascular and Interventional Society, is hosting the 2021 OEIC Annual National Scientific Meeting from September 24–25, 2021, in Orlando. OEIS aims to enhance the safety, quality and patient satisfaction of outpatient endovascular and interventional procedures, develop standards of practice for the operation of outpatient endovascular and interventional
Corindus, a Siemens Healthineers Company, announced it has been rebranded to Siemens Healthineers Endovascular Robotics, a dedicated business within the Advanced Therapies area of Siemens Healthineers. The aim of the Endovascular Robotics business is to advance interventions with robotics and change the way that care is delivered through innovations that
Cook Medical announced the appointment of John A. Kaufman, MD, MS, as Chief Medical Officer (CMO), effective July 2023. Currently, Dr. Kaufman is the inaugural Chair of the Dotter Department of Interventional Radiology, Director of the Dotter Interventional Institute, and Frederick S. Keller Professor of Interventional Radiology at the Oregon
Merit Medical Systems, Inc. announced the enrollment of the first patient in the company’s prospective, observational study of EmboCube embolization gelatin to control bleeding or hemorrhage. The EmboCube Embolization Gelatin study is designed to enroll 100 patients across multiple centers in Australia and France. The company advised that EmboCube is
You can place any content here, including Advertising. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque scelerisque lectus nec est feugiat, at eleifend sapien suscipit. Cras in neque ac nulla blandit auctor sed ut purus. Curabitur metus elit, tristique id auctor a, fermentum imperdiet felis. Maecenas imperdiet facilisis nibh at viverra. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Cras euismod rhoncus nibh, et vestibulum justo bibendum et. Quisque sed vehicula erat. Nulla cursus a nisi a tincidunt. Curabitur pulvinar, urna quis volutpat dignissim, libero est fermentum mauris, ut rutrum metus lacus at ipsum. Donec rhoncus leo eget dolor gravida ullamcorper. Suspendisse tempus, velit condimentum hendrerit ultrices, tellus libero auctor leo, non feugiat libero dui a tellus.